Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.
8h
News Medical on MSNA new way to detect inflammation using antibodies developedNearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues ...
Motorists across the country could be at risk of a £1,000 fine if they fail to tell the DVLA about certain eye conditions.
Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...
Night driving glasses claim to help you see at night when you are behind the wheel. But do they actually work, and are they ...
A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
Symptoms of diabetes can show up in various ways on your body including the extremities of your body. Here are some of the ...
Father-of-one Phillip Morris, from Newport, suffocated to death after having £12,500 gastric sleeve surgery at a private ...
UAE healthcare giant Medcare has announced the expansion of its Medical Centres network to meet the rising demand for easily ...
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price lowered by equities researchers at Bernstein Bank from $1,070.00 to $1,000.00 in a research note issued to investors on ...
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price decreased by equities research analysts at Leerink Partners from $980.00 to $862.00 in a research note issued on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results